| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 225,000 | 01 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ADVM | Adverum Biotechnologies, Inc. | 01 Mar 2023 | 1 | $0 | 4 | Chief Medical Officer | 03 Mar 2023, 16:23 |
| ADVM | Adverum Biotechnologies, Inc. | 19 Sep 2022 | 1 | -$4,570 | 4 | Chief Medical Officer | 21 Sep 2022, 20:01 |
| ADVM | Adverum Biotechnologies, Inc. | 14 Sep 2022 | 1 | $0 | 4/A | Chief Medical Officer | 21 Sep 2022, 19:55 |
| ADVM | Adverum Biotechnologies, Inc. | 17 May 2022 | 1 | +$8,228 | 4 | Chief Medical Officer | 19 May 2022, 19:43 |
| ADVM | Adverum Biotechnologies, Inc. | 07 Feb 2022 | 1 | $0 | 4 | Chief Medical Officer | 09 Feb 2022, 16:10 |
| ADVM | Adverum Biotechnologies, Inc. | 07 Feb 2022 | 0 | $0 | 3 | Chief Medical Officer | 09 Feb 2022, 16:08 |